Home Tags Biotech

Tag: Biotech

RDMD co-founders Nancy Yu and Onno Faber.

A company that calls itself the ‘Flatiron Health of rare diseases’ and is backed by Mark Zuckerberg, Bill Gates, and Jeff Bezos just raise...

A drug development platform for rare disease just announced $3 million in seed funding, led by investment companies with a network of backers that include Bill Gates, Mark Zuckerberg, and Jeff Bezos.

Samumed, a $12 billion startup that wants to cure baldness and smooth out your wrinkles, just raised even more funding as it plots an IPO

Samumed, a San Diego-based biotech is one of the highest valued healthcare startups in the US with a $12 billion valuation. On Monday, the company raised an additional $438 million, bringing its total funding to $650 million.

Akouos, a biotech startup that’s trying to tackle a $750 billion global problem, just announced it’s raised a new funding round

Akouos, the first biotech startup that's taking a precision medicine approach to hearing loss, announced a $50 million Series A funding round on Tuesday.

Ovid Therapeutics shares fall 28% as investors question new drug data

New York-based biotech company Ovid Therapeutics announced on Monday positive phase 2 trial results for its treatment for a rare disease called Angelman Syndrome. Its stock, however, fell 28% following the announcement.
The science team behind Mammoth Biosciences

A medical diagnostics startup that wants to use CRISPR technology to detect diseases just raised $23 million in venture funding

Mammoth Biosciences, a diagnostics startup that uses CRISPR proteins to detect diseases like HPV and malaria, just raised $23 million in funding to develop its technology.
23andMe CEO Anne Wojcicki explained why the company is working with GSK to develop drugs.

Here’s the email 23andMe sent its customers after GSK bought a $300 million stake in the company

"23andMe has created a research platform to enable interested customers to participate in research - to not wait for solutions to appear, but for people to come together and make discoveries happen," 23andMe's CEO wrote. "By working with GSK, we believe we will accelerate the development of breakthroughs."

We just got more information on the first positive Alzheimer’s trial in years — here’s what you need to know

In July, drugmakers Biogen and Eisai announced positive results to its experimental Alzheimer's drug, known as BAN2401. It was the first time in years that the pharmaceutical industry has had a positive Alzheimer's trial, and the news sent Biogen skyrocketing.

Why pharma giant GSK just made a $300 million bet on 23andMe’s approach to finding new medicines

The consumer genetics company 23andMe is teaming up with the UK drug giant GlaxoSmithKline to develop new drugs. As part of the four-year collaboration, GSK is committing $300 million to 23andMe and is working on an experimental drug to treat Parkinson's disease.

A company that’s taking a new approach to tackling Alzheimer’s is moving into human trials after raising $133 million

Biotech startup Alector is getting ready to put its first batch of neurodegenerative drugs into humans after raising an additional $133 million. Alector is developing treatments that harness the body's immune system to tackle conditions like Alzheimer's, and other forms of dementia.
Instead of turning to surgery, drugmakers are hoping to treat diseases like uterine fibroids and endometriosis with new medications.

A new treatment for a condition that can feel like tiny people skating on razor blades in your stomach and affects an estimated 200 million women just...

The FDA just approved elagolix, a new treatment for women living with endometriosis. Endometriosis, a condition that affects millions of women, occurs when tissue from the uterus grows outside of it, leading to cysts, heavy bleeding, and scarring.